Biomarin Pharmaceutical Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$874,565	$776,133	$825,410	$745,145
Gross Profit	579,470	636,048	675,320	593,587
EBITDA	-3,937	-5,258	319,110	263,021
EBIT	-24,375	-23,745	300,547	240,952
Net Income	-46,573	-30,744	240,532	185,686
Net Change In Cash	874,565	776,133	825,410	745,145
Free Cash Flow	58,922	340,238	168,170	157,626
Cash	1,311,679	1,250,108	1,213,816	1,048,803
Basic Shares	197,394	192,032	196,643	196,474

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,221,253	$2,853,915	$2,419,226	$2,096,039
Gross Profit	2,484,425	2,273,680	1,887,164	1,593,016
EBITDA	572,936	650,528	306,773	265,359
EBIT	493,379	554,102	202,387	163,390
Net Income	348,901	426,859	167,645	141,561
Net Change In Cash	3,221,253	2,853,915	2,419,226	2,096,039
Free Cash Flow	724,956	475,423	62,568	54,943
Cash	1,311,679	942,842	755,127	724,531
Basic Shares	197,394	196,708	191,595	188,963